Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Junck

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2010
Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomasThomas C Kwee, Craig J Galbán, Christina Tsien, et al.
NMR in Biomedicine|September 25, 2009
Intravoxel water diffusion heterogeneity imaging of human high-grade gliomasThomas C Kwee, Craig J Galbán, Christina Tsien, et al.
Journal of Neuro-Oncology|February 2, 2018
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastomaWilliam C Jackson, Christina I Tsien, Larry Junck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN task force report: management of neuropathy in cancerMichael D Stubblefield, Harold J Burstein, Allen W Burton, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Neuro-Oncology|May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsMarc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Nature Medicine|April 21, 2009
The parametric response map is an imaging biomarker for early cancer treatment outcomeCraig J Galbán, Thomas L Chenevert, Charles R Meyer, et al.
Cancer|April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium TrialSusan M Chang, Michael D Prados, W K Alfred Yung, et al.
Journal of Neuro-Oncology|April 13, 2019
Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastomaMichelle M Kim, Corey Speers, Pin Li, et al.
Translational Oncology|January 28, 2014
Impact of perfusion map analysis on early survival prediction accuracy in glioma patientsBenjamin Lemasson, Thomas L Chenevert, Theodore S Lawrence, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Journal of Magnetic Resonance Imaging : JMRI|February 27, 2010
Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomasThomas C Kwee, Craig J Galbán, Christina Tsien, et al.
NMR in Biomedicine|September 25, 2009
Intravoxel water diffusion heterogeneity imaging of human high-grade gliomasThomas C Kwee, Craig J Galbán, Christina Tsien, et al.
Journal of Neuro-Oncology|February 2, 2018
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastomaWilliam C Jackson, Christina I Tsien, Larry Junck, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN task force report: management of neuropathy in cancerMichael D Stubblefield, Harold J Burstein, Allen W Burton, et al.
Neuro-Oncology|March 28, 2002
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium StudyH Ian Robins, Susan M Chang, Michael D Prados, et al.
Neuro-Oncology|May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsMarc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Nature Medicine|April 21, 2009
The parametric response map is an imaging biomarker for early cancer treatment outcomeCraig J Galbán, Thomas L Chenevert, Charles R Meyer, et al.
Cancer|April 10, 2004
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium TrialSusan M Chang, Michael D Prados, W K Alfred Yung, et al.
Journal of Neuro-Oncology|April 13, 2019
Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastomaMichelle M Kim, Corey Speers, Pin Li, et al.
Translational Oncology|January 28, 2014
Impact of perfusion map analysis on early survival prediction accuracy in glioma patientsBenjamin Lemasson, Thomas L Chenevert, Theodore S Lawrence, et al.
Pageof 9